lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed and are posted here as part of a 12-month trial. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Generation of Functional Stem Cell-Derived CD105neg CD73low Melanocyte Precursors Guided by Defined Culture Conditions

42 Pages Posted: 10 Jan 2019

See all articles by Gabriela Zavala

Gabriela Zavala

Chilean Consortium for Regenerative Medicine

Carolina Sandoval

Universidad de los Andes, Chile

Daniel Meza

Chilean Consortium for Regenerative Medicine

Rafael Contreras

Chilean Consortium for Regenerative Medicine

Walter Gubelin

Universidad de los Andes, Chile

Maroun Khoury

Universidad de los Andes, Chile - Laboratory of Nano-Regenerative Medicine; Chilean Consortium for Regenerative Medicine - Consorcio REGENERO; Cells for Cells

More...

Abstract

Background: The generation of functional human epidermal melanocytes (HEM) from stem cells would provide an unprecedented source for cell-based therapy in vitiligo. Despite the important efforts exerted to obtain melanin-producing cells from stem cells, pre-clinical results still lack safety or scalability characteristics, essential for their translational application.  

Methods: Here, we report a rapid and efficient protocol based on defined culture conditions capable of differentiating adipose-derived stem cells (ADSC) to scalable amounts of proliferative melanocyte precursors (PreMel), within 30 days. PreMel were characterized in vitro through PCR, Western blot, flow cytometry and biochemical assays and in in vivo assays in immunocompromised mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ or NSG).  

Findings: After 30 days of differentiation, the stem-cell-derived PreMel were defined as CD105negCD73low according to changes measured in the expression of parental surface markers. In addition, the expression of MITF and active tyrosinase (TYR) and PMEL, a melanosome related protein for terminal differentiation, were also detected. Furthermore, cells were capable of synthetizing melanin and pack it into melanosomes both in vitro and in the skin of a transplanted mouse model.  

Interpretation: These results evidence a short and scalable protocol for the obtaining of proliferative melanocyte precursors or PreMel, displaying essential functional characteristics of bona fide HEM.  

Funding Statement: This work was funded by Consorcio REGENERO.

Declaration of Interests: GZ y DM receives stipends from Consorcio REGENERO, Chilean Biotechnology Company for cell therapy development. MK receives stipends from Cells for Cells, Chilean Biotechnology Company for cell therapy development. CS, RC and WG declare no conflict of interest.

Ethics Approval Statement:  All the procedures presented in this work were approved for the Ethics Committee of Universidad de los Andes. All the personal involved in animal studies was trained internally using courses available at www.aalas.org and assays were performed according to ARRIVE guidelines of the NC3Rs (National Centre for the Replacement, Refinement & Reduction of Animals in Research).

Keywords: adult stem cells; melanocytes; vitiligo; stem cells differentiation; tyrosinase

Suggested Citation

Zavala, Gabriela and Sandoval, Carolina and Meza, Daniel and Contreras, Rafael and Gubelin, Walter and Khoury, Maroun, Generation of Functional Stem Cell-Derived CD105neg CD73low Melanocyte Precursors Guided by Defined Culture Conditions (April 1, 2019). Available at SSRN: https://ssrn.com/abstract=3311840

Gabriela Zavala

Chilean Consortium for Regenerative Medicine

Santiago
Chile

Carolina Sandoval

Universidad de los Andes, Chile

Mons. Álvaro del Portillo
Las Condes
Santiago, 12.455
Chile

Daniel Meza

Chilean Consortium for Regenerative Medicine

Santiago
Chile

Rafael Contreras

Chilean Consortium for Regenerative Medicine

Santiago
Chile

Walter Gubelin

Universidad de los Andes, Chile

Mons. Álvaro del Portillo
Las Condes
Santiago, 12.455
Chile

Maroun Khoury (Contact Author)

Universidad de los Andes, Chile - Laboratory of Nano-Regenerative Medicine ( email )

Monseñor Álvaro del Portillo 12455
Santiago, 11711
Chile

Chilean Consortium for Regenerative Medicine - Consorcio REGENERO ( email )

Santiago
Chile

Cells for Cells ( email )

Santiago
Chile

Click here to go to TheLancet.com

Go to TheLancet.com

Paper statistics

Abstract Views
88
Downloads
10